| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate |
2016-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107787328-B |
| titleOfInvention |
Truncated von Willebrand factor polypeptides for the treatment of hemophilia |
| abstract |
The present invention relates to polypeptides comprising truncated von Villebrand Factor (VWF) for use in the treatment of coagulation disorders, wherein the polypeptides carry a half-life extending moiety and are VWF was administered in molar excess. |
| priorityDate |
2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |